Jean-David Bouaziz

45PUBLICATIONS
94CO-AUTHORS
Epidemiological modellingAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|May 16, 2026
Management and predictors of ICU admission in DRESS: A multicentre retrospective cohort study.

|May 29, 2025
Lichenoid graft-versus-host disease shows a high interferon score, with IFNAR1 inhibition preventing skin inflammation.

Chloé Grolleau, Thomas Poisot, Andreea Calugareanu

|Jul 31, 2024
Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema.

F Theves, C Lahuna, T Mahévas

|Oct 06, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.

L Frumholtz, J-D Bouaziz, M Battistella

|Mar 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study.

J I Silverberg, A Pinter, A Alavi

|Nov 30, 2020
Actinic cheilitis: a systematic review of treatment options.

M H Trager, K Farmer, C Ulrich

Pageof 8